A detailed history of Bank Of America Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Of America Corp holds 14,189,363 shares of NVO stock, worth $1.49 Billion. This represents 0.18% of its overall portfolio holdings.

Number of Shares
14,189,363
Previous 13,053,731 8.7%
Holding current value
$1.49 Billion
Previous $1.68 Billion 20.84%
% of portfolio
0.18%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $139 Million - $167 Million
1,135,632 Added 8.7%
14,189,363 $2.03 Billion
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $8 Million - $10.6 Million
78,322 Added 0.6%
13,053,731 $1.68 Billion
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $592 Million - $711 Million
6,746,377 Added 108.31%
12,975,409 $1.34 Billion
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $14.6 Million - $16.2 Million
-93,563 Reduced 1.48%
6,229,032 $1.01 Billion
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $58.3 Million - $70.1 Million
-440,661 Reduced 6.52%
6,322,595 $1.01 Billion
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $57.3 Million - $75.6 Million
-558,380 Reduced 7.63%
6,763,256 $915 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $13.8 Million - $17 Million
-145,136 Reduced 1.94%
7,321,636 $729 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $2.7 Million - $3.19 Million
26,163 Added 0.35%
7,466,772 $832 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $11.8 Million - $14.2 Million
126,438 Added 1.73%
7,440,609 $826 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $14.1 Million - $17.2 Million
-147,235 Reduced 1.97%
7,314,171 $819 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $13.3 Million - $16.7 Million
156,956 Added 2.15%
7,461,406 $716 Million
Q2 2021

Sep 13, 2021

BUY
$67.66 - $84.76 $494 Million - $619 Million
7,304,450 New
7,304,450 $612 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.